Concepedia

Christopher T. Cummings

CT

15

Publications

1.7K

Citations

14

H-Index

2009

Active since

Affiliations

University of Colorado Anschutz Medical Campus(Current)

University of Colorado Denver

University of North Carolina at Chapel Hill

Johns Hopkins University

University of Colorado Cancer Center

Christopher T. Cummings is an author at University of Colorado Anschutz Medical Campus specializing in medicine, tumor biology, and cell biology.

ORCID

Top concepts

Publications per year

2009–2019

15

Publications

15

Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy

Paola Maycotte, Suraj Aryal, Christopher T. Cummings et al. · Autophagy · 2012 · 394 citations · Full text

, , +18

A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop

K E Ware, Trista K. Hinz, Emily K. Kleczko et al. · Oncogenesis · 2013 · 255 citations · Full text

Mer or Axl receptor tyrosine kinase inhibition promotes apoptosis, blocks growth and enhances chemosensitivity of human non-small cell lung cancer

Rachel M.A. Linger, Richard A. Cohen, Christopher T. Cummings et al. · Oncogene · 2012 · 215 citations · Full text

, , +10

<b>UNC2025</b>, a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor

Weihe Zhang, Deborah DeRyckere, Debra M. Hunter et al. · Journal of Medicinal Chemistry · 2014 · 157 citations · Full text

, , +18

GATA6 Activates Wnt Signaling in Pancreatic Cancer by Negatively Regulating the Wnt Antagonist Dickkopf-1

Yi Zhong, Zheng Wang, Baojin Fu et al. · PLoS ONE · 2011 · 97 citations · Full text

, , +15

Rows per page

1–5 of 15